Evidence map›Paper›PMID 27102489›Full record

ReviewScience (New York, N.Y.)2016

Trained immunity: A program of innate immune memory in health and disease.

Mihai G Netea, Leo A B Joosten, Eicke Latz, Kingston H G Mills, Gioacchino Natoli, Hendrik G Stunnenberg, Luke A J O'Neill, Ramnik J Xavier

12 registry-linked trialsAbstract readReview
In one paragraph

Review in Science (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 12 registered trials, which are not on this map. Cited by 1,541 papers.

0numbers the graph read from it
0cells of the map it votes in
1,541citing papers in PubMed
92.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03305341 early_phase1active not recruitingnot on this mapstarted 2025, after this paper: background citation

Conducting an Initial Small, Controlled Clinical Pharmacology Trial to Assess for Therapeutic Biologics Activity (Proof-of-Concept) That Suggests the Potential for Clinical Benefits of COVID-19 Patients With Controlled Cancers.

TypeinterventionalSponsorHan Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairRan2025 to 2026Enrolled20ConditionsCovid19ArmsCOVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use
NCT04348370 phase4completednot on this mapstarted 2020, after this paper: background citation

Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2: A Randomized Controlled Trial to Protect Health Care Workers by Enhanced Trained Immune Responses

TypeinterventionalSponsorTexas A&M UniversityRan2020 to 2023Enrolled659ConditionsCoronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified ElsewhereArmsBCG Vaccine, Placebo Vaccine
NCT04362124 phase3withdrawnnot on this mapstarted 2020, after this paper: background citation

Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection in Medellín, Colombia, 2020

TypeinterventionalSponsorUniversidad de AntioquiaRan2020 to 2021Enrolled0ConditionsCOVID-19Armsvaccine BCG, Placebo
NCT04373291 phase3completednot on this mapstarted 2020, after this paper: background citation

Using BCG Vaccine to Enhance Non-specific Protection of Health Care Workers During the COVID-19 Pandemic. A Randomized Controlled Multi-center Trial

TypeinterventionalSponsorBandim Health ProjectRan2020 to 2021Enrolled1,293ConditionsCOVID-19, Non-specific Effects of Vaccines, Morbidity, AbsenteeismArmsBCG-Denmark, Saline
NCT04632537 phase3withdrawnnot on this mapstarted 2020, after this paper: background citation

Novel Use of an Existing Vaccine (BCG) Alliance: The NUEVA Trial

TypeinterventionalSponsorHenry M. Jackson Foundation for the Advancement of Military MedicineRan2020 to 2021Enrolled0ConditionsCOVID-19ArmsTice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine, Preservative-free saline
NCT04641858 phase4completednot on this mapstarted 2020, after this paper: background citation

BCG Vaccine to Reduce Unplanned Absenteeism Due to Illness of Health Care Workers During the COVID-19 Pandemic. A Multi-center Randomised Controlled Trial (BCG-COVID-RCT)

TypeinterventionalSponsorUniversity of Southern DenmarkRan2020 to 2022Enrolled668ConditionsCovid19, Morbidity, AbsenteeismArmsBCG-Denmark, Saline
NCT04659941 phase2unknown statusnot on this mapstarted 2020, after this paper: background citation

Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers

TypeinterventionalSponsorUniversidade Federal do Rio de JaneiroRan2020 to 2024Enrolled752ConditionsCOVID 19 VaccineArmsBCG vaccine, 0.9% sodium chloride (NaCl) saline solution
NCT04662619 nacompletednot on this mapstarted 2020, after this paper: background citation

A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis

TypeinterventionalSponsorJohnson & Johnson Consumer Inc. (J&JCI)Ran2020 to 2024Enrolled273ConditionsHealthyArmsB. infantis, Lactose Placebo
NCT04798677 nacompletednot on this mapstarted 2020, after this paper: background citation

Efficacy and Tolerability of a Nutritional Supplementation With ABBC-1, a Symbiotic Combination of Beta-glucans and Selenium and Zinc Enriched Probiotics, in Volunteers Receiving the Influenza or the Covid-19 Vaccines

TypeinterventionalSponsorAB BiotekRan2020 to 2021Enrolled72ConditionsImmunity, Vaccine Reaction, Influenza, Covid19ArmsABBC1 Immunoessential, Placebo
NCT04938323 phase2 / phase3withdrawnnot on this mapstarted 2022, after this paper: background citation

Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly (PARITIE)

TypeinterventionalSponsorHarvard Medical School (HMS and HSDM)Ran2022 to 2022Enrolled0ConditionsAcute Respiratory InfectionArmsBCG Vaccine, Placebo
NCT07182838 early_phase1active not recruitingnot on this mapstarted 2025, after this paper: background citation

Conducting an Initial Small, Controlled Clinical Pharmacology Trial to Assess for Therapeutic Biologics Activity (Proof-of-Concept) That Suggests the Potential for Clinical Benefits of HIV (+) Patients

TypeinterventionalSponsorHan Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairRan2025 to 2026Enrolled20ConditionsHIV InfectionsArmsHIV Therapeutic Biologic Mix - HIV GP160 plus BCG Vaccine Mix for percutaneous use
NCT07527247 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Using AS01 Adjuvant to Improve Immune Response in Older Adults Through Trained Immunity

TypeinterventionalSponsorSingapore General HospitalRan2025 to 2029Enrolled40ConditionsImmune System Responses and Trained Immunity After AS01 Administration, Healthy AdultArmsAS01 adjuvant (0.5 mL intramuscular), YF17D (Stamaril, Sanofi-Pasteur), Placebo (NaCl 09%, 0.5mL)
3 · Its place in the literature

Who cites it

1,541 citing papers in PubMed, 2,582 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Trained Immunity in Childhood Vaccination.Acta paediatrica (Oslo, Norway : 1992) · 2026
    Review
  9. Review
  10. Monocytes in pneumonia: Functional plasticity and innate memory (Review).International journal of molecular medicine · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Immune boosting to combat Alzheimer's disease: Position statement.Journal of Alzheimer's disease : JAD · 2026
    Article
  19. Article
  20. Article

1,481 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Mihai G NeteaDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands. mihai.netea@radboudumc.nl.
Leo A B JoostenDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
Eicke LatzInstitute of Innate Immunity, Bonn University, Bonn, Germany. Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA. German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Kingston H G MillsSchool of Biochemistry and Immunology, Trinity College, Dublin, Ireland.
Gioacchino NatoliDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Hendrik G StunnenbergDepartment of Molecular Biology, Faculties of Science and Medicine, Radboud Institute of Molecular Life Sciences, Radboud University, Nijmegen, Netherlands.
Luke A J O'NeillSchool of Biochemistry and Immunology, Trinity College, Dublin, Ireland.
Ramnik J XavierThe Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Center for Computational and Integrative Biology and Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Radboud University Nijmegen · NLTrinity College Dublin · IEEuropean Institute of Oncology · ITMassachusetts General Hospital · USRadboud Institute for Molecular Life Sciences · NLUniversity of Massachusetts Chan Medical School · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
European Research Council 310372NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

The general view that only adaptive immunity can build immunological memory has recently been challenged. In organisms lacking adaptive immunity, as well as in mammals, the innate immune system can mount resistance to reinfection, a phenomenon termed "trained immunity" or "innate immune memory." Trained immunity is orchestrated by epigenetic reprogramming, broadly defined as sustained changes in gene expression and cell physiology that do not involve permanent genetic changes such as mutations and recombination, which are essential for adaptive immunity. The discovery of trained immunity may open the door for novel vaccine approaches, new therapeutic strategies for the treatment of immune deficiency states, and modulation of exaggerated inflammation in autoinflammatory diseases.

Indexed as

AnimalsDNA MethylationEpigenesis, GeneticHistonesHumansImmunity, InnateImmunologic MemoryInfectionsInflammationInvertebratesPlantsTranscription, GeneticVaccinationVaccinesHistonesVaccines

Identifiers

PMID27102489
PMCPMC5087274
OpenAlexW2336656712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 6 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.